Your browser version may not work well with NCBI's Web applications. More information here...
1: J Exp Med. 1995 Jul 1;182(1):155-62.Click here to read Links

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G.

Department of Hematology/Oncology, Children's National Medical Center, Washington, DC 20010, USA.

Human interferon-inducible protein 10 (IP-10), a member of the alpha chemokine family, inhibits bone marrow colony formation, has antitumor activity in vivo, is chemoattractant for human monocytes and T cells, and promotes T cell adhesion to endothelial cells. Here we report that IP-10 is a potent inhibitor of angiogenesis in vivo. IP-10 profoundly inhibited basic fibroblast growth factor-induced neovascularization of Matrigel (prepared by H. K. Kleinman) injected subcutaneously into athymic mice. In addition, IP-10, in a dose-dependent fashion, suppressed endothelial cell differentiation into tubular capillary structures in vitro. IP-10 had no effect on endothelial cell growth, attachment, and migration as assayed in vitro. These results document an important biological property of IP-10 and raise the possibility that IP-10 may participate in the regulation of angiogenesis during inflammation and tumorigenesis.

PMID: 7540647 [PubMed - indexed for MEDLINE]

PMCID: PMC2192108

Patient Drug Information